Dr
Christopher
Mellor

Senior Patent Attorney

Edinburgh Office

Telephone. +44(0) 131 220 7500
Mobile. +44(0) 758 447 7868
Email. [email protected]

Experience

Chris has more than eight years’ experience in the patent profession, specialising in the field of chemistry, particularly medical devices, polymers, biochemistry, pharmaceuticals and surface chemistry. As well as drafting and prosecuting patent applications, he handles contentious EPO opposition and appeal proceedings, provides strategic advice on IP portfolios, and opinions on the infringement and validity of patents.

Specialisms

  • Household products
  • Petrochemicals
  • Pharmaceutical technologies

Industries

  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patent oppositions & appeals
  • Patents

Qualifications

Patent Attorney

Chartered (UK)
European


MCHEM

University of Oxford

PHD

University of Oxford

Recognition

MIP IP Rising Stars 2019/20

The guide highlights the best-performing non-partners who have contributed to the success of their firms and clients in recent years. Results are based on the information, including client feedback and peer responses obtained during the research for the 2019/20 edition of IP Stars.

View recognition online

Publications

MIP IP Rising Stars 2020/2021

View publication online

MIP IP Rising Stars 2019/20

View publication online

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.